Related Experiment Videos
Choosing the most appropriate therapy for lipid disorders
1Lipid Research Department, St Vincent's Hospital, Sydney, New South Wales. l.simons@notes.med.unsw.edu.au
Insights
Diet is key for managing high lipid levels to prevent heart disease. Drug therapy is used for persistent hyperlipidaemia, especially in high-risk patients, with specific medications for cholesterol or triglyceride issues.
Area of Science:
- Cardiology
- Pharmacology
- Preventive Medicine
Background:
- Hyperlipidaemia management is crucial for reducing coronary artery disease risk.
- Treatment thresholds for lipid-lowering drugs vary based on individual cardiovascular risk.
- Increasing medication options complicate the selection of appropriate lipid-lowering therapy.
Purpose of the Study:
- To clarify lipid treatment goals for practitioners.
- To guide the selection of optimal pharmacotherapy for hyperlipidaemia.
Main Methods:
- Review of current guidelines and evidence for lipid management.
- Analysis of drug classes for specific lipid abnormalities.
- Consideration of patient cardiovascular risk stratification.
Main Results:
- Dietary modification is the primary intervention for hyperlipidaemia.
- Pharmacological treatment is indicated for persistent hyperlipidaemia, particularly in high-risk individuals.
- Statins are first-line for hypercholesterolaemia, fibrates for hypertriglyceridaemia, and combinations for mixed dyslipidaemia.
Conclusions:
- Lipid-lowering drug therapy is effective and safe when indicated.
- Long-term patient compliance with medication remains a significant challenge.
- Personalized treatment strategies are essential for effective hyperlipidaemia management.
Background:
There is general acceptance of the need to treat hyperlipidaemia to reduce the risk of coronary artery disease. However, the level at which it is appropriate to introduce drug therapy varies with the cardiovascular risk of the patient. As the range of medications available increases, choosing the appropriate therapy for a patient becomes more difficult.
Objective:
To provide the practitioner with a clear view of lipid treatment goals and how to select the most appropriate treatment.
Discussion:
Diet is the cornerstone of treatment, with a discretionary use of drugs when hyperlipidaemia persists, particularly in those patients with unacceptably high cardiovascular risk. For a predominant cholesterol problem statin drugs are first choice, whereas fibrate drugs are most appropriate for hypertriglyceridaemia. For mixed hyperlipidaemia statin, fibrate or combinations may be required. Treatment is effective and safe but compliance with long term therapy remains a problem.